Galmed Pharmaceuticals
GLMD
$0.37
Share price
-4.86%
Change (1 day)
-92.01%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Total assets
Total assets on the balance sheet as of December 2023 : $16.62 M
According to Galmed Pharmaceuticals 's latest financial reports the company's total assets are $16.62 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Galmed Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $16.56 M | -54.76% |
| 2021-12-31 | $36.6 M | -30.12% |
| 2020-12-31 | $52.38 M | -32.1% |
| 2019-12-31 | $77.13 M | -14.86% |
| 2018-12-31 | $90.6 M | 361.23% |
| 2017-12-31 | $19.64 M | 19.41% |
| 2016-12-31 | $16.45 M | -32.2% |
| 2015-12-31 | $24.26 M | -26.31% |
| 2014-12-31 | $32.92 M | 19734.34% |
| 2013-12-31 | $0.16 M | -78.22% |
| 2012-12-31 | $0.76 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $12.45 M | -25.11% | 🇺🇸 USA |
 Endo International
ENDPQ | $5.13 B | 30,793.56% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.37 B | 2,158.64% | 🇺🇸 USA |
 Catalent CTLT | $9.87 B | 59,308.26% | 🇺🇸 USA |